Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Qmed Consulting Team ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   14.8% 6.0% 8.9% 8.6% 6.4% 6.7% 10.6% 10.6%   Credit score (0-100)   15 40 27 27 36 34 23 23   Credit rating   BB BBB BB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,596 2,347 1,372 1,754 2,907 4,859 0.0 0.0   EBITDA   17.6 157 112 133 238 323 0.0 0.0   EBIT   17.6 157 112 133 238 323 0.0 0.0   Pre-tax profit (PTP)   -0.4 128.7 117.4 127.1 198.6 293.1 0.0 0.0   Net earnings   -0.9 100.4 91.5 97.4 158.1 228.6 0.0 0.0   Pre-tax profit without non-rec. items   -0.4 129 117 127 199 293 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   212 312 404 501 660 888 838 838   Interest-bearing liabilities   32.2 32.7 61.0 87.4 117 334 0.0 0.0   Balance sheet total (assets)   360 1,042 1,415 1,921 1,564 2,459 838 838   Net Debt   -9.9 12.2 -86.9 13.9 -151 119 -838 -838     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,596 2,347 1,372 1,754 2,907 4,859 0.0 0.0   Gross profit growth   -29.8% 47.1% -41.6% 27.9% 65.8% 67.1% -100.0% 0.0%   Employees   3 3 2 2 3 6 0 0   Employee growth %   0.0% 0.0% -33.3% 0.0% 50.0% 100.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   360 1,042 1,415 1,921 1,564 2,459 838 838   Balance sheet change%   -34.8% 189.6% 35.8% 35.7% -18.6% 57.3% -65.9% 0.0%   Added value   17.6 157.0 111.8 132.5 237.5 323.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.1% 6.7% 8.2% 7.6% 8.2% 6.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.9% 22.5% 9.8% 8.5% 14.5% 16.3% 0.0% 0.0%   ROI %   7.6% 53.4% 29.8% 26.8% 36.9% 32.8% 0.0% 0.0%   ROE %   -0.4% 38.3% 25.6% 21.5% 27.2% 29.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   58.9% 30.0% 28.5% 26.1% 42.2% 36.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -55.9% 7.8% -77.7% 10.5% -63.6% 36.7% 0.0% 0.0%   Gearing %   15.2% 10.5% 15.1% 17.4% 17.7% 37.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   91.2% 88.6% 6.9% 19.3% 52.3% 15.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 1.4 1.4 1.4 1.7 1.6 0.0 0.0   Current Ratio   2.4 1.4 1.4 1.4 1.7 1.6 0.0 0.0   Cash and cash equivalent   42.0 20.5 147.9 73.6 268.0 215.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   212.1 312.5 404.0 501.4 659.6 888.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   6 52 56 66 79 54 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   6 52 56 66 79 54 0 0   EBIT / employee   6 52 56 66 79 54 0 0   Net earnings / employee   -0 33 46 49 53 38 0 0